Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-01

Clinical Trial Update: Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating endocrine dysfunction and growth hormone deficiency in children with optic nerve hypoplasia (Septo-optic dysplasia); results h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Somatropin (somatropin)

Snippet

Sponsor: Children's Hospital Los Angeles | Conditions: Growth Hormone Deficiency, Septo-Optic Dysplasia | Phase 4 | Status: COMPLETED | Results posted: 2015-04-01